Skip to main content

Table 1 Definitions of survival endpoints

From: Prognostic value of lymphocyte-monocyte ratio at diagnosis in Hodgkin lymphoma: a meta-analysis

Endpoints Definition
Overall survival Entry into study until death as a result of any cause
Progression-free survival Entry into study until lymphoma progression or death as a result of any cause
Event-free survival Entry into study until any treatment failure including lymphoma progression, or discontinuation of treatment for any reason including death
Lymphoma-specific survival Entry into study until time to death as a result of lymphoma
Time-to-progression Entry into study until time to lymphoma progression or death as a result of lymphoma